Trial Profile
An open label trial of omalizumab as add on to cetirizine treatment in patients with severe chronic idiopathic urticaria
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary) ; Cetirizine
- Indications Urticaria
- Focus Therapeutic Use
- 07 Dec 2015 New trial record